Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Neurosciences (Riyadh) ; 27(1): 10-15, 2022 Jan.
Article in English | MEDLINE | ID: covidwho-1622941


OBJECTIVES: To assess awareness of the neurological manifestation of COVID-19 on the Saudi population. METHODS: This was a cross-sectional study conducted using a Google Form survey to obtain responses randomly from the Saudi population between February and March 2021 using social media. RESULTS: A total of 831 participants completed the questionnaire. The distribution of the identified isolated neurological manifestations of COVOD-19 infections by participants' age was assessed among the respondents. Loss of smell (88.9%), loss of taste (86.8%), and headache (72.6%) were the most identified first manifestations among all the age groups, while stroke (13.4%) was the least identified for all ages with no statistical significance (p>0.05 for all). Regarding COVID-19 related neurological symptoms, the same was reported: loss of smell, taste, and headache were the most identified symptoms among all the age groups, while stroke was the least identified for all ages with no statistical significance (p>0.05 for all). CONCLUSION: The study concluded that awareness of COVID-19's neurological symptoms could help detect an atypical case, which can help in early intervention and its medical treatment. Moreover, the study also suggested conducting educational programs that emphasize the early identification of neurological symptoms of COVID-19.

COVID-19 , Cross-Sectional Studies , Humans , SARS-CoV-2 , Saudi Arabia/epidemiology , Surveys and Questionnaires
Neurosciences (Riyadh) ; 26(2): 158-162, 2021 Apr.
Article in English | MEDLINE | ID: covidwho-1170592


OBJECTIVES: To assess and quantify the impact COVID-19 has had thus far on ischemic stroke admission rate and severity (National Institutes of Health Stroke Scale (NIHSS) score) at a single tertiary center in Makkah, Saudi Arabia. METHODS: This is a retrospective analysis performed on admitted cases with definitive final diagnoses of transient ischemic attack (TIA) and ischemic stroke at King Abdullah Medical City in Makkah between January 1, 2020 and July 2020. RESULTS: Sixty-nine patients were included in our study, 41 of whom presented at our facility before the pandemic and 29 during the pandemic. No statistical significance was observed between rate of admission, stroke severity, and rate of thrombolysis before the COVID-19 pandemic and after the outbreak. We observed a reduction of mean arrival time after the pandemic began, as well as a reduction of hospital stay days. CONCLUSION: A 29% reduction of admission secondary to acute ischemic stroke was noted during the pandemic. However, COVID-19 did not affect acute stroke care at our institute. The study is limited because of its small sample size, as we assessed just one medical center.

COVID-19 , Ischemic Attack, Transient/epidemiology , Ischemic Stroke/epidemiology , Adult , Aged , Aged, 80 and over , Female , Hospitalization/statistics & numerical data , Humans , Intensive Care Units/statistics & numerical data , Ischemic Attack, Transient/therapy , Ischemic Stroke/therapy , Length of Stay/statistics & numerical data , Male , Middle Aged , Retrospective Studies , SARS-CoV-2 , Saudi Arabia/epidemiology , Severity of Illness Index , Sex Distribution , Stroke/epidemiology , Stroke/therapy , Tertiary Care Centers , Thrombolytic Therapy/statistics & numerical data , Time-to-Treatment/statistics & numerical data , Young Adult
Epilepsy Behav ; 112: 107323, 2020 11.
Article in English | MEDLINE | ID: covidwho-642555


OBJECTIVES: The objective of the study was to assess if patients with epilepsy (PWE) experienced an increase in seizure frequency and self-reported stress during the COVID-19 pandemic. METHODS: This is a cross-sectional study conducted in Saudi Arabia in April 2020. An electronic self-administered questionnaire was distributed to PWE via their treating neurologist. The variables included were demographic and baseline clinical characteristics (age, gender, living situation, occupational status, type of epilepsy, duration of epilepsy, number of antiepileptic medications (AEDs), presence of known psychiatric illness, and use of psychiatric medications), their seizure control in the month prior to the pandemic, perceived stress during this period of time, sleep changes, compliance changes, and change in seizure control during the pandemic. RESULTS: A total of 156 patients completed the questionnaire, with 29.5% reporting an increase in seizure frequency. Additionally, 59.4% reported an increase in self-reported stress and 71.2% experienced a significant change in their sleep during this period. Higher baseline seizure frequency, more AEDs, noncompliance, increase in self-reported stress, and sleep changes are the significant factors associated with increase in seizure frequency during the pandemic. CONCLUSION: Identifying high-risk patients for seizure recurrence is important in order to provide them with adequate support to reduce such risk.

Anticonvulsants/therapeutic use , Coronavirus Infections , Epilepsy/drug therapy , Pandemics , Pneumonia, Viral , Sleep Wake Disorders/epidemiology , Stress, Psychological/epidemiology , Adult , Betacoronavirus , COVID-19 , Cross-Sectional Studies , Employment , Epilepsy/physiopathology , Epilepsy/psychology , Female , Humans , Male , Mental Disorders/drug therapy , Mental Disorders/epidemiology , Middle Aged , Psychotropic Drugs/therapeutic use , Recurrence , SARS-CoV-2 , Saudi Arabia/epidemiology , Seizures/drug therapy , Self Report , Sleep , Sleep Wake Disorders/psychology , Stress, Psychological/psychology , Students , Surveys and Questionnaires , Treatment Outcome , Young Adult